as of 11-10-2026 3:54pm EST
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company is engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific antiviral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing. The Company's platform is based on host-mimicry and thereby has uniquely enabled the development of broad-spectrum antiviral drugs that the viruses would be unable to escape, a critical unmet need in antiviral therapeutics.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | SHELTON |
| Market Cap: | 33.7M | IPO Year: | 2008 |
| Target Price: | $6.00 | AVG Volume (30 days): | 157.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.41 | EPS Growth: | 34.92 |
| 52 Week Low/High: | $0.85 - $1.93 | Next Earning Date: | 11-24-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -3.33 | Index: | N/A |
| Free Cash Flow: | -7780332.0 | FCF Growth: | N/A |
See how NNVC stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "NNVC NanoViricides Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.